Cargando…
Doxorubicin resistant choriocarcinoma cell line derived spheroidal cells exhibit stem cell markers but reduced invasion
Cell cycle-specific cancer chemotherapy is based on the ability of a drug to halt, minimise or destroy rapidly dividing cells. However, their efficacy is limited by the emergence of a self-renewing cell pool called “cancer stem cells” (CSC). Choriocarcinoma is a tumour of trophoblastic tissue. We, i...
Autores principales: | Balahmar, Reham M., Deepak, Venkataraman, Sivasubramaniam, Shiva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300786/ https://www.ncbi.nlm.nih.gov/pubmed/35875180 http://dx.doi.org/10.1007/s13205-022-03243-x |
Ejemplares similares
-
Identification and characterisation of NANOG+/ OCT-4(high)/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines
por: Balahmar, Reham M., et al.
Publicado: (2018) -
Analysis of the p53 gene in human choriocarcinoma cell lines.
por: Yaginuma, Y., et al.
Publicado: (1995) -
Dihydromyricetin induces apoptosis in a human choriocarcinoma cell line
por: Zuo, Yanzhen, et al.
Publicado: (2018) -
Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment
por: Zhang, Baozhen, et al.
Publicado: (2018) -
Mesenchymal stem cell spheroids exhibit enhanced in-vitro and in-vivo osteoregenerative potential
por: Yamaguchi, Yuichiro, et al.
Publicado: (2014)